Overall rank by patents
#3,125
of 49,997 tracked assignees
USPTO PatentsView assignee record - 121 granted patents across 11 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Shukla ranks #3,125 of 49,997 tracked US assignees by granted-patent volume, with 121 patents across 11 technology areas.
USPTO PatentsView assignee plate
Corpus R3125 · US Corporation #3,125 · 121 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Landscape Forms, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Nobel Biocare Services · near
45 score
Pioneer Square Brands · near
45 score
Eko Sport · near
45 score
JSG IP Ventures · near
45 score
Shukla Medical · this assignee
45 score
3D Lighting… · lowest
7 score
What this shows Shukla's Innovation Score is 44.6/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Shukla Medical is a focused PatentsView assignee: 11 CPC subclasses with 19.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (30 grants) versus a trough of 2 in 2018. By volume, Shukla sits between Landscape Forms, Inc. and Edwards Japan Limited.
From 2019–2021 to 2022–2024, Shukla Medical moved from 36 to 69 grants (1.92x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #234. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Landscape Forms, Inc.
121 patents
Purac Biochem BV
121 patents
Shinkawa Ltd.
121 patents
Sunrise Memory Corporation
121 patents
Shutterfly, LLC
121 patents
Toshiba Lighting & Technology Corporation
121 patents
Shukla Medical
121 patents
Atombeam Technologies Inc.
120 patents
Edwards Japan Limited
120 patents
What this shows Shukla holds 121 patents at rank #3,126, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,126 in granted patent volume.
Other assignees with the most granted patents in Shukla's primary technology class.
Two PlainPatent-derived peer sets for Shukla, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (45 here).
Nearest assignees by average claims per patent (5.8 here).
Shukla's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 25% higher than 75% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 7 | 5.8% |
| 2018 | 2 | 1.7% |
| 2019 | 2 | 1.7% |
| 2020 | 4 | 3.3% |
| 2021 | 30 | 24.8% |
| 2022 | 17 | 14.0% |
| 2023 | 25 | 20.7% |
| 2024 | 27 | 22.3% |
| 2025partial year | 7 | 5.8% |
Top 11 of 11 technology areas
Overall rank by patents
#3,125
of 49,997 tracked assignees
44.6 out of 100
What to do with this data
Shukla Medical's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.